Goldman Sachs MSCI World Private Equity Return Tracker ETF (GTPE)
NASDAQ: GTPE · Real-Time Price · USD
53.84
-0.22 (-0.40%)
Feb 27, 2026, 4:00 PM EST - Market closed
-0.40% (1D)
| Assets | $26.88M |
| Expense Ratio | 0.50% |
| PE Ratio | 23.99 |
| Shares Out | 400,000 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 10,140 |
| Open | 53.66 |
| Previous Close | 54.06 |
| Day's Range | 53.66 - 53.84 |
| 52-Week Low | 47.70 |
| 52-Week High | 54.39 |
| Beta | n/a |
| Holdings | 1623 |
| Inception Date | Oct 21, 2025 |
About GTPE
Fund Home PageThe Goldman Sachs MSCI World Private Equity Return Tracker ETF (GTPE) is an exchange-traded fund that mostly invests in total market equity. The fund is not private equity, it is attempting to replicate the performance returns of the space. The fund aims to track an index which comprises long and short positions in publicly listed stocks, globally GTPE was launched on Oct 21, 2025 and is issued by Goldman Sachs.
Asset Class Equity
Category Global Large-Stock Blend
Region Global
Stock Exchange NASDAQ
Ticker Symbol GTPE
ETF Provider Goldman Sachs
Index Tracked MSCI World Private Equity Return Tracker Index
Top 10 Holdings
100.02% of assets| Name | Symbol | Weight |
|---|---|---|
| MXWLPERT JPMorgan Chase Bank, N.A. EQUITY | -- | 44.26% |
| MXWSPERT JPMorgan Chase Bank, N.A. FINANCING | -- | 24.32% |
| US DOLLAR | USD | 17.98% |
| GE Vernova Inc. | GEV | 2.62% |
| Eli Lilly and Company | LLY | 1.98% |
| Bristol-Myers Squibb Company | BMY | 1.88% |
| Vertex Pharmaceuticals Incorporated | VRTX | 1.87% |
| Gilead Sciences, Inc. | GILD | 1.79% |
| Broadcom Inc. | AVGO | 1.78% |
| Amphenol Corporation | APH | 1.54% |
News
Private Equity Had a Great Story. Investors May Be Tired of Hearing It.
Despite the common moniker, much of the recent success has been built around a boom in private credit as opposed to equity. There are signs that the trend has entered its baroque period.
4 months ago - Barrons